Nika Pharmaceuticals, Inc
- SEC CIK
- 0001145604
No open-market purchases or sales filed in the past year.
Current role at each company
- NIKA Nika Pharmaceuticals, IncSecretaryas of Mar 19, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nika Pharmaceuticals, Inc as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2024 (view filing)2:08 PM ET | Apr 13, 2022 | 706 daysLate | Nika Pharmaceuticals, IncPresident, CEO, CFO | PPurchaseCommon | +11.5M | $0.012 | +$137.9K | – | |
| Mar 19, 2024 (view filing)2:08 PM ET | Sep 12, 2022-Jun 2, 2023 | 554 daysLate | Nika Pharmaceuticals, IncPresident, CEO, CFO | SSaleCommon | −22.6M | $0.0182 | −$410.0K | – | 6 lots |